The neurobiological basis of cognitive impairment in Parkinson's disease. - Wikidata - awgldk - TriplyDB

The neurobiological basis of cognitive impairment in Parkinson's disease.

The neurobiological basis of cognitive impairment in Parkinson's disease.

http://www.wikidata.org/entity/Q33724698

about

Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s Disease Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease Individual differences in approach-avoidance aptitude: some clues from research on Parkinson's disease Predicting cognitive decline in Parkinson's disease: can we ask the genes?Genetic markers in biological fluids for aging-related major neurocognitive disorder Toxin-Induced Experimental Models of Learning and Memory Impairment Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.Parkinson Disease and Dementia.The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.Hippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models.Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.The relationships between mild cognitive impairment and phenotype in Parkinson's disease Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson's disease: a cross-sectional study.Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease.Parkinson's disease dementia: a neural networks perspective.Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.The effects of dopamine on digit span in Parkinson's disease.Compensatory neural mechanisms in cognitively unimpaired Parkinson disease.Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease Disrupted Nodal and Hub Organization Account for Brain Network Abnormalities in Parkinson's Disease.Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.Imaging the role of amyloid in PD dementia and dementia with Lewy bodies.Advances in the treatment of cognitive impairment in Parkinson's disease.Neuropathology of α-synuclein propagation and braak hypothesis.Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.Cognitive decline in Parkinson disease.Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.Emotional manifestations of PD: Neurobiological basis.How close are we to individualized medicine for Parkinson's disease?Polyozellin, a key constituent of the edible mushroom Polyozellus multiplex, attenuates glutamate-induced mouse hippocampal neuronal HT22 cell death.Preclinical laboratory assessments of predictors of social rank in female cynomolgus monkeys.Time-based prospective memory functioning in mild cognitive impairment associated with Parkinson's disease: relationship with autonomous management of daily living commitments.

P2860

Q24188194-9F117669-A9C4-4ABE-82F1-DD7D8018C116 Q26744782-EF722C88-19B1-48A9-A1E6-1E0651C5AB26 Q26860706-224CC51F-D110-4984-86D6-2373592AE4A5 Q27025463-014D442D-EFD7-45BA-8EBE-27CB3517881D Q27027348-8CA67850-0213-4582-A0FE-9ECF570E3624 Q28075913-CB78CFA4-2760-4C1E-9E30-6A50876E77B5 Q30244035-EB80FE8A-6427-49A8-834B-014F5EAB8809 Q30248574-0F12EB63-9E20-493C-95C0-26BD4F60C50C Q30248922-6A613029-5C55-4C04-86AA-217796E2A938 Q30276836-6706CD42-66E4-45FE-B987-D1D9FCF6510A Q30795299-D090890C-70C4-4DD9-B9A2-1A3038887FD2 Q31060511-6A78BEC6-1BBD-421A-8932-155975A6081D Q31097119-A664E71F-D8E5-4801-BEC2-59B3F7880043 Q33917203-D578493D-E24B-437F-B1F4-77B8184C75C0 Q33917300-207D5E9D-D425-49FD-9398-6AE44430DE57 Q33917311-87650B38-7CEA-45C3-8BDE-75692D2E0BB0 Q36154790-D7D8447E-06C7-4D7C-9BA6-C60375B535FA Q36186763-9CB4A630-868E-441B-B9CC-935030E1052F Q36197708-0C5CBBFC-84E8-4848-A370-4B051E2CA44C Q36655627-1C44D6C1-CB16-4F05-B6AB-557A72EBAFE3 Q36657389-3F525FD7-6E05-4FE4-986A-0D7A86F40E5F Q36680011-662D2A96-9461-481F-8730-C96D501FF465 Q36825541-C3497833-9422-4E72-BB5E-D9C5B3655AEC Q37062735-8F7DD770-AC7E-42C4-91F2-8EB398D18C18 Q37405048-B329887B-B604-49FE-8547-8AF6489D7FF0 Q37494873-67EE387A-45B9-4DFA-9F12-0E5DEE27440B Q38228098-E952F1A0-D250-440D-BBC5-89D40D7C810C Q38571668-EC383CB0-B70F-4758-8959-35C808318A4D Q38580816-04DA0113-3ECB-445E-9566-074469F541AB Q38647751-30405216-3CE1-490F-91F5-CD7CFCD76637 Q38661735-4878DAC8-81C8-4997-8544-3CF23D2F29DA Q38677697-4B26B284-2DCE-49F3-BA8C-0BA1D9629E88 Q38712774-74083439-02B5-4EAB-977C-D05DD4335C03 Q38751099-170257BC-7BED-4E04-BF0C-C037657B867B Q38761739-D9CA6E6D-40AF-4119-BE0D-AE324DFA1F6E Q38797335-979786CA-F529-4BD2-9778-535EBA29BBF6 Q38814888-8FD4DA1B-2B03-470B-8BDA-C8ABFBFDAC3E Q38833061-8B1D44B9-3F9A-4470-806B-637758A95017 Q38930402-BE8F3A0E-D63D-456E-9C73-B612FFBF147D Q38992129-3544CDD2-4A6B-44B1-9D93-8FAA2FF8EEB2

P2860

The neurobiological basis of cognitive impairment in Parkinson's disease.

http://www.wikidata.org/entity/Q33724698

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The neurobiological basis of cognitive impairment in Parkinson's disease.

@ast

The neurobiological basis of cognitive impairment in Parkinson's disease.

@en

type

label

The neurobiological basis of cognitive impairment in Parkinson's disease.

@ast

The neurobiological basis of cognitive impairment in Parkinson's disease.

@en

prefLabel

The neurobiological basis of cognitive impairment in Parkinson's disease.

@ast

The neurobiological basis of cognitive impairment in Parkinson's disease.

@en

P1433

Q33724698-7E5E1494-90B1-4420-87E2-A02BF9857724

P1476

Q33724698-9C7CDF98-A0F3-4BE3-80EF-D502E226A787

P2093

Q33724698-55C64DFA-AAEF-45C0-9A2B-08517C234AFB

P2860

Q33724698-0086153B-65E8-4592-AD76-834795B71C76

Q33724698-00F177C9-D896-4B1F-992D-2F37CE79FDFD

Q33724698-01F1D07F-8536-4CD7-B382-BBD51DDBC431

Q33724698-034AE573-2148-4C1D-B637-158C00AA0680

Q33724698-04F0D79A-4B70-4F27-881E-7E3389100286

Q33724698-0731C630-97C9-4567-9315-1CC4B5A2AF4D

Q33724698-08BFF008-4BAA-4402-A040-5D7E970C3810

Q33724698-0A119217-7E81-41A1-A696-D06B7ED95A2F

Q33724698-0C707936-EC3B-47CF-ACEF-CAF1EC7C0435

Q33724698-0CC48446-3152-449B-9F96-AA47FDB5DAB3

P304

Q33724698-80E9B700-41FD-44FB-966A-E690F221E40E

P31

Q33724698-CF45AD29-5009-4C7E-A046-252C79902875

P356

Q33724698-9034F40B-D915-4B04-BDBF-2CFD9A8CBD80

P407

Q33724698-7C0DA0A9-4452-4833-B248-A46F187C6C7B

P433

Q33724698-CE58F7EA-B1BB-4388-8C73-4F0C7A0CEFD3

P478

Q33724698-67D12729-1618-479B-BB64-32A19492C638

P50

Q33724698-054483E1-403F-4C60-B583-DDB4385CE7BC

Q33724698-41292533-712F-4E1F-AE8A-BCEE7AC9C3AE

Q33724698-53DB59E4-2245-4198-A806-A53145138D1A

P577

Q33724698-961B4781-FAB9-4B3E-96EB-C6CF747CA777

P5875

Q33724698-B79C5019-2779-4F10-8423-E4D9476CDD5D

P698

Q33724698-F75F7386-D13F-4D37-A928-F6377FCA4428

P921

Q33724698-C027307B-C475-4EE7-A173-8BD86B8D3E9D

P932

Q33724698-5739FBC9-9C30-454D-BA0B-CCC3D3B89558

P356

P1433

Movement Disorders

P1476

The neurobiological basis of cognitive impairment in Parkinson's disease.

@en

P2093

Jay S Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

A large study reveals no association between APOE and Parkinson's disease

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Genome-wide association study reveals genetic risk underlying Parkinson's disease

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors

alpha-Synuclein locus triplication causes Parkinson's disease

Dopamine and the regulation of cognition and attention

Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

P304

634-650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.25857

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Glenda Halliday

James B Leverenz

Charles H Adler

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261770940

http://www.w3.org/2001/XMLSchema#string

P698

24757112

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4049032

http://www.w3.org/2001/XMLSchema#string